Author： Seabrook G.R. Shepheard S.L. Williamson D.J. Tyrer P. Rigby M. Cascieri M.A. Harrison T. Hargreaves R.J. Hill R.G.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.317, Iss.1, 1996-12, pp. : 129-135
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Robineau P. Lonchampt M. Kucharczyk N. Krause J.E. Regoli D. Fauchere J.-L. Prost J.-F. Canet E.
European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. :
Access to resources
Recommend
SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist
By Anthes J.C. Chapman R.W. Richard C. Eckel S. Corboz M. Hey J.A. Fernandez X. Greenfeder S. McLeod R. Sehring S. Rizzo C. Crawley Y. Shih N.-Y. Piwinski J. Reichard G. Ting P. Carruthers N. Cuss F.M. Billah M. Kreutner W. Egan R.W.
European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. :
By Westra-De Vlieger J.F. Van Den Wijngaard P.W.J. Koster A.S. Wilting J. Leysen J. Van Heuven-Nolsen D. Nijkamp F.P.
European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. :
By Giuliani S. Guelfi M. Toulouse M. Bueno L. Lecci A. Tramontana M. Criscuoli M. Maggi C.A.
European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. :